| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 01/11/2012 | EP1566380B1 Isoquinoline compounds and medicinal use thereof |
| 01/11/2012 | CN102317293A RAF inhibitors and their uses |
| 01/11/2012 | CN101522689B Pyridooxazepine progesteron receptor modulators |
| 01/11/2012 | CN101146811B Hiv integrase inhibitors |
| 01/10/2012 | US8093381 Method of synthesis of fluoroquinolones |
| 01/10/2012 | US8093380 Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections |
| 01/10/2012 | US8093272 Heteroaryl substituted cyclohexyl-1,4-diamine compounds |
| 01/10/2012 | US8093242 Crystalline forms of a pyridine derivative |
| 01/10/2012 | US8093238 Fused thiazole derivatives as kinase inhibitors |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2408853C Process |
| 01/10/2012 | CA2124259C Galenical formulations |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012001107A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 01/05/2012 | WO2011107970A3 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
| 01/05/2012 | WO2011106248A3 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/05/2012 | US20120004328 Lilian surrogate |
| 01/05/2012 | US20120004220 Selective androgen receptor modulators (sarms) and uses thereof |
| 01/05/2012 | US20120004165 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2803996A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/04/2012 | EP2402350A1 New water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins. |
| 01/04/2012 | EP2402340A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2402339A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2401915A1 Pyrazolopyridine compounds |
| 01/04/2012 | EP2401282A1 Method for the production of amorphous rifaximin |
| 01/04/2012 | EP2401276A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
| 01/04/2012 | EP2300482B1 ANNELLATED 4-(INDAZOLYL)-1,4-DIHYDROPYRIDINE DERIVATIVES AS c-Met MEDIATORS |
| 01/04/2012 | EP2078026B1 Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| 01/04/2012 | EP1986645B1 Glucokinase activators |
| 01/04/2012 | EP1833827B9 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 01/04/2012 | EP1687283B1 Method for determining fk506 |
| 01/04/2012 | CN101511845B Spiro antibiotic derivatives |
| 01/03/2012 | US8088928 Sirtuin modulating compounds |
| 01/03/2012 | US8088816 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
| 01/03/2012 | US8088792 Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors |
| 01/03/2012 | US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/03/2012 | CA2660917C Process for producing benzoxazine derivative and production intermediate thereof |
| 01/03/2012 | CA2551723C Single-layer organic electroluminescent device |
| 01/03/2012 | CA2495060C Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications |
| 01/03/2012 | CA2495058C C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants |
| 01/03/2012 | CA2445835C 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 12/29/2011 | WO2011163355A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 12/29/2011 | WO2011161262A1 Evaporable organically semiconductive material and use thereof in an optoelectronic component |
| 12/29/2011 | WO2011161030A1 Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators |
| 12/29/2011 | US20110319613 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses |
| 12/29/2011 | US20110319612 Elimination of heterogeneous or mixed cell population in tumors |
| 12/29/2011 | US20110319434 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof |
| 12/29/2011 | US20110319401 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of xlf-iii-43 |
| 12/29/2011 | US20110319394 Fused heterocyclic compounds |
| 12/29/2011 | US20110319392 Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors |
| 12/29/2011 | US20110319380 Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof |
| 12/29/2011 | US20110319378 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
| 12/29/2011 | CA2803156A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 12/28/2011 | EP2399918A1 Ring compound |
| 12/28/2011 | EP2125831B1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 12/28/2011 | CN102295652A 一种甲磺酸帕珠沙星合成工艺的改进方法 An improved method for acid methyl pazufloxacin synthesis process |
| 12/27/2011 | US8084603 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors |
| 12/27/2011 | US8084596 Regulated apoptosis |
| 12/27/2011 | US8084442 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 12/22/2011 | WO2011158959A1 Process for production of intermediate for cyclic carbodiimide compound |
| 12/22/2011 | WO2011158958A1 Method for producing carbodiimide |
| 12/22/2011 | WO2011158833A1 Agent for treating hcv infection |
| 12/22/2011 | US20110313153 5-ht4 inhibitors for treating airway diseases, in particular asthma |
| 12/22/2011 | US20110312990 Diamine Derivatives |
| 12/22/2011 | US20110312954 Mineralocorticoid receptor antagonist and methods of use |
| 12/22/2011 | US20110312952 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 12/22/2011 | US20110312934 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
| 12/22/2011 | US20110312903 Fluorination of organic compounds |
| 12/22/2011 | US20110311482 Hepatitis C Virus Inhibitors |
| 12/22/2011 | CA2802874A1 Polymorphic forms of rifaximin |
| 12/22/2011 | CA2802477A1 Agent for treating hcv infection |
| 12/21/2011 | EP2397462A2 Compounds, compositions and methods of treatment for heart failure |
| 12/21/2011 | EP2396323A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1 |
| 12/21/2011 | EP2167484B1 Condensed anthranilamide insecticides |
| 12/21/2011 | CN102285997A 一种氯代烯丙基β-内酰胺抗生素中间体的制备方法 A method for preparing allyl chloride β- lactam antibiotic intermediates |
| 12/21/2011 | CN101010281B 肾素抑制剂的替代合成方法及其中间体 Renin inhibitors and intermediates alternative synthesis method |
| 12/20/2011 | US8080654 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors |
| 12/20/2011 | CA2493821C Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 12/15/2011 | WO2011155624A1 Cyclic carbodiimide compound |
| 12/15/2011 | US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/15/2011 | US20110306607 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
| 12/15/2011 | US20110306593 Gamma secretase modulators |
| 12/14/2011 | EP2393812A1 Substituted spiro-amides as b1r modulators |
| 12/14/2011 | EP2393362A1 Novel benzodiazepine derivatives |
| 12/14/2011 | EP1668012B1 Method for preparing cucurbiturils |
| 12/14/2011 | CN102282457A 确定西罗莫司稳定性的方法和制备其稳定形式的工艺 Determining the stability of sirolimus methods and processes for preparing their stable form |
| 12/14/2011 | CN102282148A 11-(2-吡咯烷-1-基-乙氧基)-14,19-二氧杂-5,7,26-三氮杂-四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2(26),3,5,8,10,12(27),16,21,23-十烯柠檬酸盐 11- (2-pyrrolidin-1-yl - ethoxy) -14,19- dioxa -5,7,26- triaza - tetracyclo [19.3.1.1 (2,6) .1 (8 , 12)] twenty-seven carbon-1 (25), 2 (26), 3,5,8,10,12 (27), 16,21,23- ten alkenyl citrate |
| 12/14/2011 | CN102282145A γ分泌酶调节剂 γ secretase modulators |
| 12/14/2011 | CN102276628A 氟喹诺酮类化合物及其合成方法 Fluoroquinolones and synthesis method |
| 12/14/2011 | CN102276627A 吡啶并杂环衍生物 Pyridine and heterocyclic derivatives |
| 12/14/2011 | CN101248070B 7-氨基亚烷基-杂环喹诺酮和萘啶酮 7- aminoalkylene - quinolone and nalidixic heterocyclic ketone |
| 12/13/2011 | US8076354 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 12/13/2011 | US8076350 3H-(4's)-1'-azaspiro[benzofuran-2,4']-tricyclo[3.3.1.13,7]decane; for therapy of memory disorder, cognitive disorder, neurodegeneration, and neurodevelopmental disorder; attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment |
| 12/13/2011 | US8076322 [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists |
| 12/13/2011 | CA2600832C Hiv integrase inhibitors |
| 12/13/2011 | CA2476008C Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 12/08/2011 | WO2011153509A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |